Synthetic integrin antibodies discovered by yeast display reveal αV subunit pairing preferences with β subunits

References

• Campbell ID, Humphries MJ. Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol. 2011;3(3):a004994–16. doi:10.1101/cshperspect.a004994. PMID: 21421922.
   PubMed Web of Science ®Google Scholar
• Springer TA, Dustin ML. Integrin inside-out signaling and the immunological synapse. Curr Opin Cell Biol. 2012;24:107–15. doi:10.1016/j.ceb.2011.10.004. PMID: 22129583.
   PubMed Web of Science ®Google Scholar
• Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol. 2007;25(1):619–47. doi:10.1146/annurev.immunol.25.022106.141618. PMID: 17201681.
   PubMedGoogle Scholar
• Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature. 2004;432(7013):59–67. doi:10.1038/nature02976. PMID: 15378069.
   PubMed Web of Science ®Google Scholar
• Xiong JP, Stehle T, Zhang R, Joachimiak A, Frech M, Goodman SL, Arnaout MA. Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand. Science. 2002;296(5565):151–55. doi:10.1126/science.1069040. PMID: 11884718.
   PubMed Web of Science ®Google Scholar
• Nagae M, Re S, Mihara E, Nogi T, Sugita Y, Takagi J. Crystal structure of α5β1 integrin ectodomain: atomic details of the fibronectin receptor. J Cell Biol. 2012;197:131–40. doi:10.1083/jcb.201111077. PMID: 22451694.
   PubMed Web of Science ®Google Scholar
• Schumacher S, Dedden D, Nunez RV, Matoba K, Takagi J, Biertumpfel C, Mizuno N. Structural insights into integrin α5β1 opening by fibronectin ligand. Sci Adv. 2021;7(19):eabe9716. doi:10.1126/sciadv.abe9716. PMID: 33962943.
   PubMed Web of Science ®Google Scholar
• Dong X, Hudson NE, Lu C, Springer TA. Structural determinants of integrin β-subunit specificity for latent TGF-β. Nat Struct Molecul Biol. 2014;21(12):1091–96. doi:10.1038/nsmb.2905. PMID: 25383667.
   PubMed Web of Science ®Google Scholar
• Roy A, Shi L, Chang A, Dong X, Fernandez A, Kraft JC, Li J, Le VQ, Winegar RV, Cherf GM, et al. De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8. Nat Commun. 2023;14(1):5660. doi:10.1038/s41467-023-41272-z. PMID: 37704610.
   PubMed Web of Science ®Google Scholar
• Wang J, Su Y, Iacob RE, Engen JR, Springer TA. General structural features that regulate integrin affinity revealed by atypical αVβ8. Nat Commun. 2019;10(1):5481. doi:10.1038/s41467-019-13248-5. PMID: 31792290.
   PubMedGoogle Scholar
• Bouvard D, Brakebusch C, Gustafsson E, Aszodi A, Bengtsson T, Berna A, Fassler R. Functional consequences of integrin gene mutations in mice. Circ Res. 2001;89(3):211–23. doi:10.1161/hh1501.094874. PMID: 11485971.
   PubMed Web of Science ®Google Scholar
• Jo MH, Li J, Jaumouille V, Hao Y, Coppola J, Yan J, Waterman CM, Springer TA, Ha T. Single-molecule characterization of subtype-specific β1 integrin mechanics. Nat Commun. 2022;13(1):7471. doi:10.1038/s41467-022-35173-w. PMID: 36463259.
   PubMed Web of Science ®Google Scholar
• Sheppard D. Roles of αv integrins in vascular biology and pulmonary pathology. Curr Opin Cell Biol. 2004;16:552–57. doi:10.1016/j.ceb.2004.06.017. PMID: 15363806.
   PubMed Web of Science ®Google Scholar
• Coller BS, Shattil SJ. The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood. 2008;112(8):3011–25. doi:10.1182/blood-2008-06-077891. PMID: 18840725.
   PubMed Web of Science ®Google Scholar
• Brandenberger R, Schmidt A, Linton J, Wang D, Backus C, Denda S, Muller U, Reichardt LF. Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin α8β1 in the embryonic kidney. J Cell Biol. 2001;154(2):447–58. doi:10.1083/jcb.200103069. PMID: 11470831.
   PubMed Web of Science ®Google Scholar
• Slack RJ, Macdonald SJF, Roper JA, Jenkins RG, Hatley RJD. Emerging therapeutic opportunities for integrin inhibitors. Nat Rev Drug Discov. 2022;21(1):60–78. doi:10.1038/s41573-021-00284-4. PMID: 34535788.
   PubMed Web of Science ®Google Scholar
• Mitjans F, Sander D, Adan J, Sutter A, Martinez JM, Jaggle CS, Moyano JM, Kreysch HG, Piulats J, Goodman SL. An anti-αv-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice. J Cell Sci. 1995;108(Pt 8):2825–38. doi:10.1242/jcs.108.8.2825. PMID: 7593323.
   PubMedGoogle Scholar
• Goodman SL, Holzemann G, Sulyok GA, Kessler H. Nanomolar small molecule inhibitors for αvβ6, αvβ5, and αvβ3 integrins. J Med Chem. 2002;45(5):1045–51. doi:10.1021/jm0102598. PMID: 11855984.
   PubMed Web of Science ®Google Scholar
• Akiyama SK, Yamada SS, Chen WT, Yamada KM. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol. 1989;109(2):863–75. doi:10.1083/jcb.109.2.863. PMID: 2527241.
   PubMed Web of Science ®Google Scholar
• Li S, Wang H, Peng B, Zhang M, Zhang D, Hou S, Guo Y, Ding J. Efalizumab binding to the LFA-1 αL I domain blocks ICAM-1 binding via steric hindrance. Proc Natl Acad Sci U S A. 2009;106(11):4349–54. doi:10.1073/pnas.0810844106. PMID: 19258452.
   PubMed Web of Science ®Google Scholar
• Yu Y, Zhu J, Mi LZ, Walz T, Sun H, Chen J, Springer TA. Structural specializations of α4β7, an integrin that mediates rolling adhesion. J Cell Biol. 2012;196(1):131–46. doi:10.1083/jcb.201110023. PMID: 22232704.
   PubMed Web of Science ®Google Scholar
• Yu Y, Schurpf T, Springer TA. How natalizumab binds and antagonizes α4 integrins. J Biol Chem. 2013;288:32314–25. doi:10.1074/jbc.M113.501668. PMID: 24047894.
   PubMed Web of Science ®Google Scholar
• Sheehan J, Marasco WA, Crowe JE, Boraschi D, Rappuoli R. Phage and yeast display. Microbiol Spectr. 2015;3(1):AID-0028–2014. doi:10.1128/microbiolspec.AID-0028-2014. PMID: 26104550.
   Google Scholar
• Boder ET, Raeeszadeh-Sarmazdeh M, Price JV. Engineering antibodies by yeast display. Arch Biochem Biophys. 2012;526:99–106. doi:10.1016/j.abb.2012.03.009. PMID: 22450168.
   PubMed Web of Science ®Google Scholar
• Clackson T, Hoogenboom HR, Griffiths AD, Winter G. Making antibody fragments using phage display libraries. Nature. 1991;352(6336):624–28. doi:10.1038/352624a0.
   PubMed Web of Science ®Google Scholar
• Gai SA, Wittrup KD. Yeast surface display for protein engineering and characterization. Curr Opin Struct Biol. 2007;17(4):467–73. doi:10.1016/j.sbi.2007.08.012. PMID: 17870469.
   PubMed Web of Science ®Google Scholar
• Cheresh DA. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA. 1987;84(18):6471–75. doi:10.1073/pnas.84.18.6471. PMID: 2442758.
   PubMed Web of Science ®Google Scholar
• Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest. 1983;72(1):325–38. doi:10.1172/jci110973. PMID: 6308050.
   PubMed Web of Science ®Google Scholar
• Graff C, Palmer C, Blakeley B, Mullen T. Gardet a inventors; anti-integrin antibodies and uses thereof. World Intellectual Property Organization; 2020 Apr 08.
   Google Scholar
• Li J, Su Y, Xia W, Qin Y, Humphries MJ, Vestweber D, Cabanas C, Lu C, Springer TA. Conformational equilibria and intrinsic affinities define integrin activation. Embo J. 2017;36(5):629–45. doi:10.15252/embj.201695803. PMID: 28122868.
   PubMed Web of Science ®Google Scholar
• Violette SM, Weinreb PH, Simon KJ, Sheppard D, Leone DR, inventors; Biogen Idec MA Inc. Regents of the University of Californias assignee.^assignees. Anti-αvβ6 antibodies. USA; 2008 Dec 16.
   Google Scholar
• Taub R, Gould RJ, Garsky VM, Ciccarone TM, Hoxie J, Friedman PA, Shattil SJ. A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. J Biol Chem. 1989;264(1):259–65. doi:10.1016/S0021-9258(17)31252-8. PMID: 2909518.
   PubMed Web of Science ®Google Scholar
• Pampori N, Hato T, Stupack DG, Aidoudi S, Cheresh DA, Nemerow GR, Shattil SJ. Mechanisms and consequences of affinity modulation of integrin αVβ3 detected with a novel patch-engineered monovalent ligand. J Biol Chem. 1999;274(31):21609–16. doi:10.1074/jbc.274.31.21609.
   PubMed Web of Science ®Google Scholar
• Kraft S, Diefenbach B, Mehta R, Jonczyk A, Luckenbach GA, Goodman SL. Definition of an unexpected ligand recognition motif for αvβ6 integrin. J Biolog Chem. 1999;274(4):1979–85. doi:10.1074/jbc.274.4.1979. PMID: 9890954.
   PubMed Web of Science ®Google Scholar
• Dong X, Zhao B, Iacob RE, Zhu J, Koksal AC, Lu C, Engen JR, Springer TA. Force interacts with macromolecular structure in activation of TGF-β. Nature. 2017;542(7639):55–59. doi:10.1038/nature21035. PMID: 28117447.
   PubMed Web of Science ®Google Scholar
• Li J, Springer TA. Energy landscape differences among integrins establish the framework for understanding activation. J Cell Biol. 2018;217(1):397–412. doi:10.1083/jcb.201701169. PMID: 29122968.
   PubMed Web of Science ®Google Scholar
• Sun G, Guillon E, Holley SA. Integrin intra-heterodimer affinity inversely correlates with integrin activatability. Cell Rep. 2021;35(10):109230. doi:10.1016/j.celrep.2021.109230. PMID: 34107244.
   PubMed Web of Science ®Google Scholar
• Lin FY, Li J, Xie Y, Zhu J, Huong Nguyen TT, Zhang Y, Zhu J, Springer TA. A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell. 2022;185(19):3533–50.e27. doi:10.1016/j.cell.2022.08.008. PMID: 36113427.
   PubMed Web of Science ®Google Scholar
• Wittrup KD. Protein engineering by cell-surface display. Curr Opin Biotechnol. 2001;12(4):395–99. doi:10.1016/s0958-1669(00)00233-0. PMID: 11551469.
   PubMed Web of Science ®Google Scholar
• Ewert S, Huber T, Honegger A, Pluckthun A. Biophysical properties of human antibody variable domains. J Mol Biol. 2003;325(3):531–53. doi:10.1016/s0022-2836(02)01237-8. PMID: 12498801.
   PubMed Web of Science ®Google Scholar
• Ewert S, Honegger A, Pluckthun A. Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach. Biochem. 2003;42(6):1517–28. doi:10.1021/bi026448p. PMID: 12578364.
   PubMed Web of Science ®Google Scholar
• Weinreb PH, Simon KJ, Rayhorn P, Yang WJ, Leone DR, Dolinski BM, Pearse BR, Yokota Y, Kawakatsu H, Atakilit A, et al. Function-blocking integrin αVβ6 monoclonal antibodies: distinct ligand-mimetic and nonligand-mimetic classes. J Biol Chem. 2004;279(17):17875–87. doi:10.1074/jbc.M312103200. PMID: 14960589.
   PubMed Web of Science ®Google Scholar
• Dodagatta-Marri E, Ma HY, Liang B, Li J, Meyer DS, Chen SY, Sun KH, Ren X, Zivak B, Rosenblum MD, et al. Integrin αVβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy. Cell Rep. 2021;36(1):109309. doi:10.1016/j.celrep.2021.109309. PMID: 34233193.
   PubMed Web of Science ®Google Scholar
• Wang X, Guillem-Marti J, Kumar S, Lee D, Alamo KAE, Werther R, Zhao YT, Nguyen A, Kopyeva I, Huang B, et al. De novo design of α5β1-specific modulating proteins for enhanced cell-material interactions in regenerative medicine. BiorXiv. 2024.
   Google Scholar